As the "violation of relevant laws and regulations" by the Weibo ban continues to ferment on the whole network, the capital behind the Lilac Garden may have to "tremble three times". As the leading enterprise of domestic Internet medical treatment, Lilac Garden, which is highly sought after by capital, has completed 5 rounds of financing, and in addition to Hillhouse and Tencent, Trusttrust Capital, which is backed by Singapore's Temasek, has also escorted it.
On August 10, Global Tiger Finance learned from the Weibo platform that the Lilac Garden series of media accounts were banned, including 5 accounts of Lilac Garden, Lilac Doctor, Lilac Mother, Lilac Life Research Institute, and Lilac Garden Medication Assistant.
Among them, the official micro of Lilac Garden stopped changing on August 5, the Lilac Garden Medication Assistant stopped changing on August 8, and the other three accounts were suspended on August 6.
The last time Lilac Garden became the focus of public opinion on the whole network was in April this year, when the shanghai epidemic occurred, when the citizens received Lianhua Qing plague, the platform released an article called "Don't eat Lianhua Qing Plague to prevent the new crown", which pointed out that Lianhua Qing Plague not only can not prevent the new crown, but also may bring side effects.
As soon as the article was published, the stock price of Yiling Pharmaceutical, which produced Lianhua Qing plague, fell sharply.
For the ban on the lilac garden, netizens have mixed attitudes, and some people clap their hands and say that they are fast. It is not known when Lilac Garden will be "unsealed", but many of the investors behind it may be nervous about the ban.
"Lilac" flowering period?
Multiple of its accounts were banned
On August 10, the Lilac Garden regeneration incident.
Global Tiger Finance learned from the Weibo platform that accounts such as "Lilac Garden", "Lilac Doctor", "Lilac Life Research Institute", "Lilac Mother" and "Lilac Garden Medication Assistant" under the Lilac Garden Group have been restricted from speaking.
On the WeChat public platform, some accounts such as "Lilac Garden", "Lilac Doctor" and "Lilac Mother" did not push content to users on August 9. According to the past push law, these accounts push 3 pieces of medical and health content to users every day.
The reason for the ban on the Lilac Garden series of Microblogs is not yet known, and the Reason given by the Weibo platform is that it "violates relevant laws and regulations". As of August 10, the number of Weibo accounts of "Lilac Doctor" reached a maximum of 5.96 million, and the number of Weibo accounts of "Lilac Garden" was 2.17 million.
Image source: Weibo
According to public information, Lilac Garden is a digital medical and health technology enterprise, connecting doctors, researchers, patients, hospitals, biomedical enterprises and insurance companies through professional and authoritative content sharing and interaction, rich and comprehensive medical data accumulation, and high-quality digital medical services.
Since its establishment 22 years ago, Lilac Garden has 5.5 million professional users, including 2.1 million doctor users, accounting for 71% of the total number of doctors in China.
This is not the first time that Dr. Lilac has been pushed into the limelight of public opinion this year, in the first half of this year, Yiling Pharmaceutical donated Lianhua Qing plague to the city at the time of the outbreak of the epidemic in Shanghai, and at this time, Lilac Garden released an article called "Don't Eat Lianhua Qing Plague to Prevent New Crown".
The article elaborates on the following three measures that can be used to prevent COVID-19 under the current scientific conditions, the first, physical blockade, that is, the conventional approach to prevention of the new crown virus, including wearing masks and maintaining social distancing; The second induces an immune response and reduces the infectivity of the released virus; The third type of pre-exposure prophylaxis (PrEP) refers to the fact that there is currently no infection with the virus, no exposure to a high-risk environment, and early medication is used to prevent infection.
After talking in detail about the three measures to prevent the new crown, Dr. Lilac gave the conclusion that in the three ways known so far, even the flower qing plague is not established, and the effect of preventing the new crown virus cannot be achieved, and said that if there is no disease, do not take medicine indiscriminately, even the flower qing plague is the same.
Just the day after Dr. Ding Xiang published the article, on April 18, Yiling Pharmaceutical opened at a drop stop price of 32.39 yuan / share, and walked out of two consecutive drop stop boards.
In this regard, Yiling Pharmaceutical replied that the company has published 35 experimental and clinical research papers (15 published abroad), of which the real-world research paper "The Effectiveness and Safety of Lianhua Qingpeng Capsules in Preventing Novel Coronavirus Pneumonia: Prospective Open Label Controlled Trial" was published in the international journals Audio-Based Complementary and Alternative Medicine.
In addition, Dr. Lilac has published several articles on Chinese medicine.
Global Tiger Finance learned from the "Lilac Garden" public account that nearly a quarter of the articles in the "Lilac Garden" 3073 article contained Chinese medicine-related content.
Image source: "Lilac Garden" public number
Behind the capital surfaced,
Hillhouse and Tencent are among them
As a digital medical and health enterprise, the capital behind Lilac Garden cannot be underestimated.
According to public information, the founder of Lilac Garden is Li Tiantian, who graduated from Harbin Medical University with a master's degree in tumor immunology. Born in 2000, he founded The Lilac Garden.
According to the APP, there are currently 23 companies in which Li Tiantian works as a legal person, most of which are health management, Internet hospitals, and medical technology companies.
At the time of the rise of a number of Internet medical treatment, Lilac Garden has long occupied a dominant position in the industry. Ten years after the establishment of Lilac Garden, it ushered in its first financing.
In January 2010, Lilac Garden received a SERIES investment of US$2 million from DCM, and in December of the following year, it received Series B financing, led by Shunwei Fund and followed by DCM.
Subsequently, in September 2014, Lilac Garden received Tencent's $70 million Series C strategic investment; In April 2018, in the D round of financing, it was led by TrustTrust with an investment of US$100 million, and in December 2020, it completed a financing of US$500 million, of which Zhixin led the investment again, and Tencent and Hillhouse Venture Capital followed suit.
Looking closely at the capital behind the Lilac Garden, in addition to getting the platform of Hillhouse, Tencent and other big guys, the most worth mentioning is Trusttrust Capital.
According to public information, Trusttrust Capital is a private equity investment fund founded in 2006 to focus on investing in the Chinese market, with offices in Shanghai, Hong Kong and Boston.
TrustTrust Capital's core assets include Jiahui Medical Services, WeWork co-working space, online community Douban, and Trusttrust Global Media TGM, which is committed to creating high-quality children's educational content, and its funds are mainly from University Foundations in the United States such as New York University and Stanford University, as well as international investment institutions such as Temasek in Singapore.
As the largest investor of Lilac Garden, in addition to Lilac Garden, Trusttrust Capital has also invested in a number of "popular science platforms" active in the domestic Internet, such as Squirrel Club, Fruit Shell Network, Elephant Guild, Paper Clip, etc., and many of the above platforms have been banned before.
Singapore Temasek, the financier behind TrustTrust Capital, as the largest consortium helmed by Singapore's first lady, is 100% controlled by the Singapore Ministry of Finance, operating the equity of 36 Guolian enterprises such as the Singapore Development Bank, and managing 23 subsidiaries in a controlling manner, including 14 wholly owned companies, 7 listed companies and 2 limited liability companies.
It is worth mentioning that in Temasek's investment map, there is no shortage of Pfizer and Fosun. Temasek's many investment sectors include pharmaceuticals, including BioNTech in Germany, which is a partner of Pfizer and Fosun.
Image source: Global Tiger Finance Finishing
Such a strong capital background has also supported the gradual growth of Lilac Garden in recent years. At present, in addition to the Weibo matrix, Lilac Garden also has a series of platforms and products such as Lilac Talent Network, Lilac Pass, Lilac Guest, Medication Assistant, Lilac Doctor, Lilac Mother, PubMed Chinese Network, Investigation Sect, Lilac Conference and so on.
The "net red doctor" MCN model is not easy to do,
Lilac Garden drinking "barley tea"
Lilac Garden has always been the main focus of reliable health science, and like many Internet medical platforms, Lilac Garden has previously been involved in online consultation.
Global Tiger Finance learned from the public account of Lilac Garden that under a number of popular science tweets, users can choose to add relevant doctor contact information for special medical consultation. At the same time, on multiple social platforms, it has also set off the wind of "Lilac Doctor" recommendation.
For a time, the brand of Lilac Garden established a high degree of credibility in the hearts of mass consumers, and Lilac Garden also began to integrate the professional ability of doctors to output to the C-end with the professional doctor resources accumulated over the past 20 years, and its practice of "D+ C" ("D" for doctor, "C" for consumer) strategy.
While creating online consultation, Dr. Lilac is more like opening the MCN mode of "net red doctor". Relevant MCN institutional personnel told Tiger Finance that the identity of relevant practitioners with medical backgrounds has more commercial value, and with their medical backgrounds on relevant Internet platforms, they can obtain higher credibility and thus monetize traffic business models.
However, with the landing of the Internet medical regulatory policy last year and the release of the industry rectification of medical personnel, the industry's model for "net red doctors" is more like crossing the river by feeling the stones.
Specifically, nine ministries and commissions, including the National Health Commission and the Ministry of Industry and Information Technology, issued a notice in June 2022 requiring serious investigation and punishment of medical institution staff using their positions and identities to live stream goods.
At the same time, the "Internet Diagnosis and Treatment Supervision Rules (Trial)" released at the same time shows that Internet diagnosis and treatment is included in the overall medical service supervision system, and the rules stipulate that patients can provide case certificates before online follow-up consultation, which also invisibly increases the difficulty of Obtaining customers for Internet medical treatment.
After the online first consultation was explicitly prohibited, the development of online health consultation business was mainly expanded, and the proportion of online consultation business was relatively reduced.
At that time, Lilac Garden was also seeking changes while developing medical consultation knowledge and paying. Dr. Lilac, whose revenue depends on knowledge to pay, has gradually aligned with leading Internet medical institutions such as Ali Health and Jingdong Health, opening up the development of the big health sector business.
At the same time, in November 2021, Lilac Garden officially announced that its digital marketing service for enterprises will operate as an independent brand in the future, named dmc (DXY Marketing Center), nicknamed "Barley Tea", which means that Lilac Garden has begun to integrate its resources and pay more attention to the integration of B-end enterprises. Judging from the current sales of the Lilac Garden APP, its products involve health care products, electronic products, skin care products, etc.
In addition, the To D (for doctors) business of Lilac Garden has developed and grown in recent years, including community forums, medication assistants, clove open classes, clove talents, and clove medical examinations, with business covering 5.5 million core users, mainly for China's core doctor groups, covering all public and private medical institutions except township hospitals.
This article originated from the Global Tiger Finance app